Verona Pharma plc I9SA.F Stock
Verona Pharma plc Price Chart
Verona Pharma plc I9SA.F Financial and Trading Overview
| Verona Pharma plc stock price | 12.5 EUR |
| Previous Close | 19.2 EUR |
| Open | 18.6 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 18.6 - 19 EUR |
| 52 Week Range | 3.56 - 25.2 EUR |
| Volume | 100 EUR |
| Avg. Volume | 24 EUR |
| Market Cap | 1.54B EUR |
| Beta (5Y Monthly) | 0.191549 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.73 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.83 EUR |
I9SA.F Valuation Measures
| Enterprise Value | 1.28B EUR |
| Trailing P/E | N/A |
| Forward P/E | -17.431192 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3370.2476 |
| Price/Book (mrq) | 5.4239225 |
| Enterprise Value/Revenue | 2791.59 |
| Enterprise Value/EBITDA | -20.753 |
Trading Information
Verona Pharma plc Stock Price History
| Beta (5Y Monthly) | 0.191549 |
| 52-Week Change | 380.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.2 EUR |
| 52 Week Low | 3.56 EUR |
| 50-Day Moving Average | 18.94 EUR |
| 200-Day Moving Average | 16.18 EUR |
I9SA.F Share Statistics
| Avg. Volume (3 month) | 24 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 79.46M |
| Float | 56.02M |
| Short Ratio | N/A |
| % Held by Insiders | 3.14% |
| % Held by Institutions | 69.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -13589.29% |
| Gross Margin | 24.45% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.79% |
| Return on Equity (ttm) | -30.074% |
Income Statement
| Revenue (ttm) | 458K EUR |
| Revenue Per Share (ttm) | 0.006 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 112K EUR |
| EBITDA | -61609000 EUR |
| Net Income Avi to Common (ttm) | -60607000 EUR |
| Diluted EPS (ttm) | -0.84 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 291.42M EUR |
| Total Cash Per Share (mrq) | 3.67 EUR |
| Total Debt (mrq) | 20.52M EUR |
| Total Debt/Equity (mrq) | 7.42 EUR |
| Current Ratio (mrq) | 11.571 |
| Book Value Per Share (mrq) | 3.503 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -51132000 EUR |
| Levered Free Cash Flow (ttm) | -30743624 EUR |
Profile of Verona Pharma plc
| Country | Germany |
| State | N/A |
| City | London |
| Address | 3 More London Riverside |
| ZIP | SE1 2RE |
| Phone | 44 20 3283 4200 |
| Website | https://www.veronapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 35 |
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Q&A For Verona Pharma plc Stock
What is a current I9SA.F stock price?
Verona Pharma plc I9SA.F stock price today per share is 12.5 EUR.
How to purchase Verona Pharma plc stock?
You can buy I9SA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Verona Pharma plc?
The stock symbol or ticker of Verona Pharma plc is I9SA.F.
Which industry does the Verona Pharma plc company belong to?
The Verona Pharma plc industry is Biotechnology.
How many shares does Verona Pharma plc have in circulation?
The max supply of Verona Pharma plc shares is 81.08M.
What is Verona Pharma plc Price to Earnings Ratio (PE Ratio)?
Verona Pharma plc PE Ratio is now.
What was Verona Pharma plc earnings per share over the trailing 12 months (TTM)?
Verona Pharma plc EPS is -0.73 EUR over the trailing 12 months.
Which sector does the Verona Pharma plc company belong to?
The Verona Pharma plc sector is Healthcare.